Obesity Surgery

, Volume 19, Issue 3, pp 363–368 | Cite as

Bariatric Surgery, Safety and Type 2 Diabetes

Review

Abstract

Obesity and type 2 diabetes (T2D) represent major health concerns in the USA. Weight loss is the most important aspect in T2D management, as it reduces both morbidity and mortality. Available lifestyle, behavioral, and pharmacological strategies provide just mild to moderate weight loss. The greatest degree of T2D prevention or T2D amelioration in obese subjects has been reported in subjects who underwent bariatric surgery. In the current review, we will describe various types of bariatric surgery, related safety profiles, and their effect on T2D, as well as the potential mechanisms involved in the remission of T2D. Finally, we hereby examine whether bariatric surgery may be considered a treatment for T2D in pregnant women, children, adolescents and subjects at least 65 years old.

Keywords

Bariatric Obesity RYGB Type 2 diabetes 

References

  1. 1.
    Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001;24(11):1936–40, Nov.PubMedCrossRefGoogle Scholar
  2. 2.
    Zimmet P, Shaw J, Alberti KG. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med 2003;20(9):693–702, Sep.PubMedCrossRefGoogle Scholar
  3. 3.
    Wing RR, Marcus MD, Epstein LH, et al. Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 1987;10(5):563–6, Sep–Oct.PubMedCrossRefGoogle Scholar
  4. 4.
    Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351(26):2683–93, Dec 23.PubMedCrossRefGoogle Scholar
  5. 5.
    NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991;115(12):956–61, Dec 15.Google Scholar
  6. 6.
    Halverson JD, Wise L, Wazna MF, et al. Jejunoileal bypass for morbid obesity. A critical appraisal. Am J Med 1978;64(3):461–75, Mar.PubMedCrossRefGoogle Scholar
  7. 7.
    Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996;119(3):261–8, Mar.PubMedCrossRefGoogle Scholar
  8. 8.
    Mason EE. Vertical banded gastroplasty for obesity. Arch Surg 1982;117(5):701–6, May.PubMedGoogle Scholar
  9. 9.
    Suter M, Jayet C, Jayet A. Vertical banded gastroplasty: long-term results comparing three different techniques. Obes Surg 2000;10(1):41–6, Feb; discussion 7.PubMedCrossRefGoogle Scholar
  10. 10.
    Tretbar LL, Taylor TL, Sifers EC. Weight reduction. Gastric plication for morbid obesity. J Kans Med Soc 1976;77(11):488–90, Nov.PubMedGoogle Scholar
  11. 11.
    Kuzmak LI, Thelmo W, Abramson DL, et al. Reversible adjustable gastric banding. Surgical technique. Eur J Surg Acta Chir 1994;160(10):569–71, Oct.Google Scholar
  12. 12.
    Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998;8(3):267–82, Jun.PubMedCrossRefGoogle Scholar
  13. 13.
    American Society of Bariatric Surgery. Brief history and summary of bariatric surgery. Chapter 4. http://www.asbs.org/html/patients/bpds.html (2005).
  14. 14.
    Mason EE, Ito C. Gastric bypass. Ann Surg 1969;170(3):329–39, Sep.PubMedCrossRefGoogle Scholar
  15. 15.
    Crookes PF. Surgical treatment of morbid obesity. Annu Rev Med 2006;57:243–64.PubMedCrossRefGoogle Scholar
  16. 16.
    American Society of Bariatric Surgery. Brief history and summary of bariatric surgery. Chapter 3. http://www.asbs.org/html/patients/bypass.html (2005).
  17. 17.
    Santoro S, Malzoni CE, Velhote MC, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg 2006;16(10):1371–9, Oct.PubMedCrossRefGoogle Scholar
  18. 18.
    Santoro S, Velhote MC, Malzoni CE, et al. Preliminary results from digestive adaptation: a new surgical proposal for treating obesity, based on physiology and evolution. Sao Paulo Med J 2006;124(4):192–7, Jul 6.PubMedCrossRefGoogle Scholar
  19. 19.
    Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 2004;14(4):492–7, Apr.PubMedCrossRefGoogle Scholar
  20. 20.
    Miller K, Hoeller E, Aigner F. The implantable gastric stimulator for obesity: An update of the european experience in the LOSS (Laparoscopic Obesity Stimulation Survey) study. Treat Endocrinol 2006;5(1):53–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004;14(7):991–8, Aug.PubMedCrossRefGoogle Scholar
  22. 22.
    Regan JP, Inabnet WB, Gagner M, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003;13(6):861–4, Dec.PubMedCrossRefGoogle Scholar
  23. 23.
    Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg 2004;14(5):671–6, May.PubMedCrossRefGoogle Scholar
  24. 24.
    Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005;142(7):547–59, Apr 5.PubMedGoogle Scholar
  25. 25.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. Jama 2004;292(14):1724–37, Oct 13.PubMedCrossRefGoogle Scholar
  26. 26.
    Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299(3):316–23, Jan 23.PubMedCrossRefGoogle Scholar
  27. 27.
    Dixon AF, Dixon JB, O'Brien PE. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab 2005;90(2):813–9, Feb.PubMedCrossRefGoogle Scholar
  28. 28.
    Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346(21):1623–30, May 23.PubMedCrossRefGoogle Scholar
  29. 29.
    Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402(6762):656–60, Dec 9.PubMedCrossRefGoogle Scholar
  30. 30.
    Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000;141(11):4255–61, Nov.PubMedCrossRefGoogle Scholar
  31. 31.
    Korner J, Bessler M, Cirilo LJ, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005;90(1):359–65, Jan.PubMedCrossRefGoogle Scholar
  32. 32.
    Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology 2007;132(6):2116–30, May.PubMedCrossRefGoogle Scholar
  33. 33.
    Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238(4):467–84, Oct; discussion 84–5.PubMedGoogle Scholar
  34. 34.
    Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005;353(3):249–54, Jul 21.PubMedCrossRefGoogle Scholar
  35. 35.
    Patti ME, McMahon G, Mun EC, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005;48(11):2236–40, Nov.PubMedCrossRefGoogle Scholar
  36. 36.
    Xu G, Stoffers DA, Habener JF, et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999;48(12):2270–6, Dec.PubMedCrossRefGoogle Scholar
  37. 37.
    le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243(1):108–14, Jan.PubMedCrossRefGoogle Scholar
  38. 38.
    Greenberg I, Perna F, Kaplan M, et al. Behavioral and psychological factors in the assessment and treatment of obesity surgery patients. Obes Res 2005;13(2):244–9, Feb.PubMedCrossRefGoogle Scholar
  39. 39.
    Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232(4):515–29, Oct.PubMedCrossRefGoogle Scholar
  40. 40.
    Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3–60 month follow-up. Obes Surg 2000;10(3):233–9, Jun.PubMedCrossRefGoogle Scholar
  41. 41.
    Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234(3):279–89, Sep; discussion 89–91.PubMedCrossRefGoogle Scholar
  42. 42.
    Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass: a prospective, randomized trial. Obes Surg 2001;11(3):284–92, Jun.PubMedCrossRefGoogle Scholar
  43. 43.
    Ogden C, Carroll M, McDowell M, Flegal K. Obesity among adults in the United States—no statistically significant change since 2003–2004. http://www.cdc.gov/nchs/data/databriefs/db01.pdf (2007). Accessed 2007.
  44. 44.
    Martin LF, Finigan KM, Nolan TE. Pregnancy after adjustable gastric banding. Obstet Gynecol 2000;95(6 Pt 1):927–30, Jun.PubMedCrossRefGoogle Scholar
  45. 45.
    Marceau P, Kaufman D, Biron S, et al. Outcome of pregnancies after biliopancreatic diversion. Obes Surg 2004;14(3):318–24, Mar.PubMedCrossRefGoogle Scholar
  46. 46.
    Dixon JB, Dixon ME, O'Brien PE. Birth outcomes in obese women after laparoscopic adjustable gastric banding. Obstet Gynecol 2005;106(5 Pt 1):965–72, Nov.PubMedGoogle Scholar
  47. 47.
    Skull AJ, Slater GH, Duncombe JE, et al. Laparoscopic adjustable banding in pregnancy: safety, patient tolerance and effect on obesity-related pregnancy outcomes. Obes Surg 2004;14(2):230–5, Feb.PubMedCrossRefGoogle Scholar
  48. 48.
    ACOG Committee Opinion number 315, September 2005. Obesity in pregnancy. Obstet Gynecol 2005;106(3):671–5, Sep.Google Scholar
  49. 49.
    Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295(13):1549–55, Apr 5.PubMedCrossRefGoogle Scholar
  50. 50.
    Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346(11):802–10, Mar 14.PubMedCrossRefGoogle Scholar
  51. 51.
    Lawson ML, Kirk S, Mitchell T, et al. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 2006;41(1):137–43, Jan; discussion -43.PubMedCrossRefGoogle Scholar
  52. 52.
    Tsai WS, Inge TH, Burd RS. Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med 2007;161(3):217–21, Mar.PubMedCrossRefGoogle Scholar
  53. 53.
    Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004;114(1):217–23, Jul.PubMedCrossRefGoogle Scholar
  54. 54.
    CDC. Obesity among adults in the United States—no statistically significant change since 2003–2004. http://www.cdc.gov/nchs/pressroom/07newsreleases/obesity.htm (2007). Accessed 2007.
  55. 55.
    CDC. NCHS-FACSTATS-diabetes. http://www.cdc.gov/nchs/fastats/diabetes.htm (2008). Accessed 2006.
  56. 56.
    Sosa JL, Pombo H, Pallavicini H, et al. Laparoscopic gastric bypass beyond age 60. Obes Surg 2004;14(10):1398–401, Nov–Dec.PubMedCrossRefGoogle Scholar
  57. 57.
    Sugerman HJ, DeMaria EJ, Kellum JM, et al. Effects of bariatric surgery in older patients. Ann Surg 2004;240(2):243–7, Aug.PubMedCrossRefGoogle Scholar
  58. 58.
    Abu-Abeid S, Keidar A, Szold A. Resolution of chronic medical conditions after laparoscopic adjustable silicone gastric banding for the treatment of morbid obesity in the elderly. Surg Endosc 2001;15(2):132–4, Feb.PubMedCrossRefGoogle Scholar
  59. 59.
    Varela JE, Wilson SE, Nguyen NT. Outcomes of bariatric surgery in the elderly. Am Surg 2006;72(10):865–9, Oct.PubMedGoogle Scholar
  60. 60.
    Flum DR, Salem L, Elrod JA, et al. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 2005;294(15):1903–8, Oct 19.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  1. 1.Laboratory of Molecular Genetics of Complex & Monogenic Disorders, Department of Medicine and Cellular & Molecular Physiology, H044Penn State Milton S. Hershey Medical CenterHersheyUSA
  2. 2.Penn State University College of MedicineHersheyUSA
  3. 3.Sbarro Institute for Cancer Research & Molecular Medicine, Center for Biotechnology and Department of BiologyTemple University’s College of Science & TechnologyPhiladelphiaUSA
  4. 4.Molecular Biology LaboratoryBios Biotech Multi-Diagnostic Health CenterRomeItaly

Personalised recommendations